Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Palmitoleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.66 |
| ▸ | FABP3 | P05413 | 9/20 | 0.96 |
| ▸ | TERT | O14746 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | BLM | P54132 | 2/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | FABP4 | P15090 | 2/20 | 0.66 |
| ▸ | GMNN | O75496 | 1/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.66 |
| ▸ | MMP2 | P08253 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vaccenic Acid SCHEMBL15452907 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL11324221 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL28219314 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Nervonic Acid SCHEMBL27632364 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL29196 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Erucic Acid SCHEMBL31135511 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL29193 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL28385238 | 0.98 | FABP3 (0.92) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL1203413 | 0.98 | FABP3 (0.92) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL28478796 | 0.98 | FABP3 (0.92) | FABP3TERTMAPTBLMHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113789039-B | Biodegradable polyester heat shrinkable film and preparation method thereof | 江苏景宏新材料科技有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114456478-A | Antistatic master batch for plastics and plastic film containing antistatic master batch | 山东星达新材料有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-114074469-A | Polyester film with high barrier property and preparation and application thereof | 河南源宏高分子新材料有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-113789039-A | Biodegradable polyester heat shrinkable film and preparation method thereof | 江苏景宏新材料科技有限公司 | 2021-12-14 | — | — | CN | claimed |
| US-9233191-B2 | Drug-coated medical devices | INNORA GMBH (DE) | 2016-01-12 | — | — | US | claimed |
| EP-2793967-B1 | DRUG-COATED MEDICAL DEVICES | INNORA GMBH (DE) | 2015-08-26 | — | — | EP | claimed |
| US-20140322291-A1 | Drug-Coated Medical Devices | INNORA GMBH (DE) | 2014-10-30 | — | — | US | claimed |
| EP-2793967-A1 | DRUG-COATED MEDICAL DEVICES | Innora GmbH (DE) | 2014-10-29 | — | — | EP | claimed |
| WO-2013091722-A1 | DRUG-COATED MEDICAL DEVICES | INNORA GMBH (DE) | 2013-06-27 | — | — | WO | claimed |
| WO-2013092416-A1 | DRUG-COATED MEDICAL DEVICES | INNORA GMBH (DE) | 2013-06-27 | — | — | WO | claimed |
| EP-4692260-A1 | KIT FOR THREE-COMPONENT COATING COMPOSITION, THREE-COMPONENT COATING COMPOSITION, AND IN-MOLD COATING METHOD | Kansai Paint Co., Ltd (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260021615-A1 | COATING COMPOSITION AND IN-MOLD COATING METHOD | KANSAI PAINT CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| US-12485593-B2 | Method for forming in-mold coating multi-layer coating film | KANSAI PAINT CO., LTD. (JP) | 2025-12-02 | — | — | US | disclosed |
| US-12325805-B2 | Coating composition and in-mold coating method | KANSAI PAINT CO., LTD. (JP) | 2025-06-10 | — | — | US | disclosed |
| US-20250144859-A1 | METHOD FOR FORMING IN-MOLD COATING MULTI-LAYER COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2025-05-08 | — | — | US | disclosed |
| WO-2013091722-A1 | DRUG-COATED MEDICAL DEVICES | INNORA GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092416-A1 | DRUG-COATED MEDICAL DEVICES | INNORA GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
| US-20130161856-A1 | METHODS OF PRODUCING A TITANIUM DIOXIDE PIGMENT AND IMPROVING THE PROCESSABILITY OF TITANIUM DIOXIDE PIGMENT PARTICLES | TRONOX LLC (US) | 2013-06-27 | — | — | US | disclosed |
| US-20080061270-A1 | Oxygen-Absorbing Composition And Packaging Material | KURARAY CO., LTD (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1769845-A1 | OXYGEN-ABSORBING COMPOSITION AND PACKAGING MATERIAL | Kuraray Co., Ltd. (JP) | 2007-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021615-A1 | COATING COMPOSITION AND IN-MOLD COATING METHOD | VIM, VCL, C9 | PTGS1 4096/4885FABP3 4730/4885TERT 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.